Skip to main content
SpringerLink
Log in

What Makes the Elderly Person an Expensive Patient? The Role of Cardiovascular Disease, Comorbidity and Treatment

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lopez AD, Murray CCJL. The global burden of disease, 1990-2020. Nature Medicine 1998; 4: 1241-1243.

    PubMed  Google Scholar 

  2. Sharpe N, Doughty R. Epidemiology of heart failure and ventricular dysfunction. Lancet 1998; 352: 3-7.

    PubMed  Google Scholar 

  3. Davis RC, Hobbs FDR, Lip GYH. ABC of heart failure-history and epidemiology. Br Med J 2000; 320: 39-42.

    Google Scholar 

  4. Mair FS, Crowley TS, Bundred PE. Prevalence, aetiology and management of heart failure in general practice. Br J General Pract 1996; 46: 77-79.

    Google Scholar 

  5. Campbell AJ, Busby WJ, Robertson MC, Lum CL, Langlois JA, Morgan FC. Disease, impairment, disability and social handicap: A community based study of people aged 70 years and over. Disabil Rehabil 1994; 16: 72-79.

    PubMed  Google Scholar 

  6. McMurray J, Hart W, Rhodes G. An evaluation of the cost of heart failure to the National Health Service in the UK. Br J Health Econ 1993; 6: 99-110.

    Google Scholar 

  7. Stewart S, Marley JE, Horowitz JD. Effects of a multidisciplinary, homebased intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: A randomised controlled study. Lancet 1999; 354: 1077-1083.

    PubMed  Google Scholar 

  8. Warlow CP. Epidemiology of stroke. Lancet 1998; 352: SIII1-SIII4.

    PubMed  Google Scholar 

  9. Asplund K, Berman P, Blomstrand C, et al. How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke 1997; 28: 2139-2144.

    PubMed  Google Scholar 

  10. Wheeldon NM. Atrial fibrillation and anticoagulant therapy. Eur Heart J 1995; 16: 302-312.

    PubMed  Google Scholar 

  11. Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials. Lancet 2000; 355: 865-872.

    PubMed  Google Scholar 

  12. Miettinen TA, Pyorala K, Olsson AG, et al. Cholesterollowering therapy in women and elderly patients with myocardial infarction or angina pectoris-findings from the Scandinavian Simvastatin Survival Study (4S). Circulation 1997; 96: 4211-4218.

    PubMed  Google Scholar 

  13. Playford DA, Watts GF. Management of lipid disorders in the elderly. Drugs Aging 1997; 10: 444-462.

    PubMed  Google Scholar 

  14. Chen YT, Vaccarino V, Williams CS, Butler J, Berkman LF, Krumholz HM. Risk factors for heart failure in the elderly: A prospective community based study. Am J Med 1999; 106: 605-612.

    PubMed  Google Scholar 

  15. Turner RC, Milins H, Neil HAW, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23). Br Med J 1998; 316: 823-828.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Geriatric Medicine, University of Liverpool, Liverpool, UK, L69 36A

    Michael Lye

Authors
  1. Michael Lye
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lye, M. What Makes the Elderly Person an Expensive Patient? The Role of Cardiovascular Disease, Comorbidity and Treatment. Cardiovasc Drugs Ther 15, 355–358 (2001). https://doi.org/10.1023/A:1012718900923

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012718900923

Keywords

Search

Navigation